Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ANVSANVS
14 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in ANNOVIS BIO INC

Yes. Citadel Advisors holds 243,682 shares of ANVS (Annovis Bio), worth $453,249, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$453,249

Current Shares

243,682

Total Value Change

+$203,249

Total Shares Change

+234,719

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
243,682
-
$453,2490.0%$1.86
33
2025-Q4
Exited
0
-100.0%
$00.0%$3.46
0
2025-Q3
Increased
174,345
+494.5%
$360,8940.0%$2.04
38
2025-Q2
New
29,326
-
$63,6370.0%$2.05
32
2025-Q1
Exited
0
-100.0%
$00.0%$1.65
0
2024-Q4
Increased
215,207
+109.6%
$1.1M0.0%$5.08
41
2024-Q3
New
102,692
-
$827,6980.0%$8.10
34
2024-Q2
Exited
0
-100.0%
$00.0%$5.76
0
2024-Q1
New
1
-
$120.0%$11.90
17
2022-Q1
Exited
0
-100.0%
$00.0%$13.65
0
2021-Q4
Increased
59,147
+58.9%
$1M0.0%$18.15
36
2021-Q3
New
37,222
-
$1.2M0.0%$31.34
35
2021-Q2
Exited
0
-100.0%
$00.0%$83.85
0
2021-Q1
New
8,963
-
$250,0000.0%$27.98
32

Other major holders of ANVS: VOLORIDGE INVESTMENT MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., MARSHALL WACE, LLP, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used